Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 9 August 2023
Kuros Biosciences Reports Results for First Half 2023
Kuros Interim Results, 2023
English version
Press Release, 13 July 2023
Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial
Minutes of the AGM, 8 May 2023
German version
Press Release, 8 May 2023
Annual General Meeting of Kuros Biosciences approves all resolutions
Press Release, 27 April 2023
Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023